HIGH-VOLUME · HOSP-MID
glipizide Side Effects
glipizide (also sold as Glucotrol) is HIGH-VOLUME in this FAERS book #122 of 524 by FAERS report count. Signature opener: HOSP-MID - 29.9% mention hospitalization (17,788 reports).
Data updated 2026-05-15
- 59,560
- FAERS reports
FAERS voluntary reports, 2004 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
glipizide: 29.9% mention hospitalization (17,788 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #122 of 524 by FAERS report count.
High-report extract for glipizide (Glucotrol): 59,560 FAERS rows (2004-2025). Top named reactions: BLOOD GLUCOSE INCREASED, NAUSEA, DIARRHOEA. Outcome stamps DEATH-HEAVY · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2004–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
BLOOD GLUCOSE INCREASED leads 6,677 of 59,560 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (15,168 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (5,214 reports, 8.8%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 2,027 |
| COMPLETED SUICIDE | 554 |
| RENAL FAILURE | 342 |
| MYOCARDIAL INFARCTION | 314 |
| CARDIAC FAILURE CONGESTIVE | 309 |
| CARDIAC ARREST | 243 |
| PNEUMONIA | 243 |
| DYSPNOEA | 231 |
| BLADDER CANCER | 229 |
| ACUTE KIDNEY INJURY | 228 |
| CHRONIC KIDNEY DISEASE | 223 |
| SEPSIS | 215 |
| ASTHENIA | 209 |
| HYPOTENSION | 201 |
| PAIN | 194 |
| RESPIRATORY FAILURE | 190 |
| ANAEMIA | 175 |
| TOXICITY TO VARIOUS AGENTS | 173 |
| CARDIO-RESPIRATORY ARREST | 170 |
| NAUSEA | 163 |
Reactions in Hospitalization Reports
Hospitalization mid-share (17,788, 29.9%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| MYOCARDIAL INFARCTION | 1,296 |
| CARDIAC FAILURE CONGESTIVE | 1,239 |
| DYSPNOEA | 1,208 |
| NAUSEA | 1,118 |
| PNEUMONIA | 1,008 |
| FALL | 984 |
| DIARRHOEA | 971 |
| BLOOD GLUCOSE INCREASED | 921 |
| ASTHENIA | 911 |
| FATIGUE | 879 |
| VOMITING | 858 |
| ACUTE KIDNEY INJURY | 847 |
| CEREBROVASCULAR ACCIDENT | 810 |
| HYPOGLYCAEMIA | 795 |
| RENAL FAILURE | 786 |
| DIZZINESS | 755 |
| PAIN | 735 |
| ANAEMIA | 697 |
| CHEST PAIN | 680 |
| DEHYDRATION | 678 |
How to read glipizide FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-MID)
FAERS holds 59,560 voluntary reports linked to glipizide (Glucotrol), 2004-2025. Death is listed on 5,214 (8.8%). Hospitalization appears on 17,788 (29.9%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; HOSP-MID is the page opener, not a per-patient risk.
Read with glipizide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 59,013 FAERS cases (Δ 547 lighter vs glipizide); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 60,533 FAERS cases (Δ 973 heavier vs glipizide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 58,495 FAERS cases (Δ 1,065 lighter vs glipizide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 58,038 FAERS cases (Δ 1,522 lighter vs glipizide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 53.4 pp vs glipizide's DEATH-HEAVY): CASELOAD · HOSP-MID.
glipizide stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.